The Effects of Omega-3 Fatty Acids on Peripheral Arterial Disease II (OMEGA-PAD II)
The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and Inflammation II
Sponsor: University of California, San Francisco
This PHASE2 trial investigates Peripheral Arterial Disease and is currently completed. University of California, San Francisco leads this study, which shows 9 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Aug 2019 — Jan 2021 [monthly]
Completed PHASE2
-
Jun 2018 — Aug 2019 [monthly]
Completed PHASE2
▶ Show 4 earlier versions
-
Jan 2018 — Jun 2018 [monthly]
Completed PHASE2
Status: Unknown Status → Completed
-
Jul 2017 — Jan 2018 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
-
Feb 2017 — Jul 2017 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Feb 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .